Combined targeting of BCL-2 and BCR-ABL tyrosine kinase eradicates chronic myeloid leukemia stem cellsBing Z. Carter, Michael Andreeff, Joel D. Leverson et al.|Science Translational Medicine|2016Cited by 172
Survivin is highly expressed in CD34+38− leukemic stem/progenitor cells and predicts poor clinical outcomes in AMLBing Z. Carter, Steven M. Kornblau, Yihua Qiu et al.|Blood|2012Cited by 88
Apoptosis repressor with caspase recruitment domain is regulated by MAPK/PI3K and confers drug resistance and survival advantage to AMLPo Yee Mak, B. Z. Carter, Michael Andreeff et al.|APOPTOSIS|2013Cited by 27